Abstract:Background: Diabetic wounds are a common complication of diabetes, with alarming disability and mortality rates. Ferroptosis plays an essential role in the occurrence and development of diabetes mellitus and its complications, suggesting that mitigating ferroptosis can be used as a potential therapeutic strategy. Resveratrol (RSV) can promote the angiogenesis of diabetic wounds, but its molecular mechanism is unclear, and RSV has a role in regulating ferroptosis. Therefore, we speculated that RSV could promote the angiogenesis of diabetic wounds and accelerate wound healing by regulating ferroptosis. Methods: In this study, we investigated the effects of RSV on human umbilical vein endothelial cells (HUVECs) treated with advanced glycation end-products (AGEs), focusing primarily on cell proliferation and markers associated with ferroptosis. The methods employed included the CCK-8 assay for cell proliferation, ROS determination, Fe²⁺ measurement, scratch and tube formation assays, and transcriptome analysis. To evaluate the effectiveness of RSV in promoting wound healing, we established a type 2 diabetes rat model and created a skin injury model. Wound healing rates were assessed, and tissue samples were analyzed using hematoxylin and eosin (H&E) staining, immunohistochemistry, immunofluorescence, and Western blotting. Additionally, levels of glutathione (GSH) and malondialdehyde (MDA) were measured to evaluate oxidative stress and lipid peroxidation. Result: Upon treatment of HUVECs with AGEs, we observed a decrease in cell viability and induction of ferroptosis. RSV can alleviate ferroptosis in AGEs-treated HUVECs. Further investigation through transcriptome analysis and Western blotting revealed that RSV alleviates ferroptosis in AGE-treated HUVECs by modulating the activity of nuclear factor erythroid 2-related factor 2 (Nrf2). In vivo experiments using a diabetic rat skin injury model confirmed that both RSV and Ferrostatin-1 (Fer-1) enhance wound healing and angiogenesis. This effect was associated with the regulation of ferroptosis marker proteins including GPX4, SLC7A11, and ACSL4. Additionally, in the diabetic rat groups treated with RSV and Fer-1, we noted increased expression of Nrf2, vascular endothelial growth factor (VEGF), and CD31 proteins compared to the diabetic rat control group. Conclusion: In diabetic wounds, AGEs can lead to ferroptosis in HUVECs. RSV can inhibit AGE-induced ferroptosis in HUVECs, further promoting angiogenesis in diabetic wounds, and ultimately accelerating wound healing.

Autophagosomes Defeat Ferroptosis by Decreasing Generation and Increasing Discharge of Free Fe2+ in Skin Repair Cells to Accelerate Diabetic Wound Healing

PF-PEG@ASIV-EXO Hydrogel Accelerates Diabetic Wound Healing by Ferroptosis Resistance and Promoting Angiogenesis

Dual response Hst1@CBTC hydrogel promoting diabetic wounds healing by improving mitochondrial autophagy and inhibiting ferroptosis via Nrf2/HO-1

MMP-9 responsive hydrogel promotes diabetic wound healing by suppressing ferroptosis of endothelial cells

Targeting Ferroptosis Promotes Diabetic Wound Healing Via Naf2 Activation

Study on the mechanism of activating SIRT1/Nrf2/p62 pathway to mediate autophagy-dependent ferroptosis to promote healing of diabetic foot ulcers

Precise Diabetic Wound Therapy: PLS Nanospheres Eliminate Senescent Cells Via DPP4 Targeting and PARP1 Activation

Autologous Platelet-Rich Gel Accelerates Diabetic Wound Healing Through Inhibition of Ferritinophagy

Resveratrol promotes diabetic wound healing by inhibiting ferroptosis in vascular endothelial cells

Targeting ferroptosis promotes diabetic wound healing via Nrf2 activation

In Situ Formation of Ferrous Sulfide in Glycyrrhizic Acid Hydrogels to Promote Healing of Multi-Drug Resistant Staphylococcus Aureus-Infected Diabetic Wounds.

Efficient Angiogenesis-Based Diabetic Wound Healing/Skin Reconstruction through Bioactive Antibacterial Adhesive Ultra-Violet Shielding Nanodressing with Exosome Release.

Efficient Angiogenesis-Based Diabetic Wound Healing/Skin Reconstruction Through Bioactive Antibacterial Adhesive Ultraviolet Shielding Nanodressing with Exosome Release

Functional extracellular matrix hydrogel modified with MSC‐derived small extracellular vesicles for chronic wound healing

Potentiation Effect on Accelerating Diabetic Wound Healing Using 2-N,6-o-sulfated Chitosan-Doped PLGA Scaffold

Injectable hydrogel harnessing foreskin mesenchymal stem cell-derived extracellular vesicles for treatment of chronic diabetic skin wounds

Hydrogen Sulfide Improves Wound Healing Via Restoration of Endothelial Progenitor Cell Functions and Activation of Angiopoietin-1 in Type 2 Diabetes

Exosomes Derived from Autologous Dermal Fibroblasts Promote Diabetic Cutaneous Wound Healing Through the Akt/β-catenin Pathway

Plasma endothelial cells-derived extracellular vesicles promote wound healing in diabetes through YAP and the PI3K/Akt/mTOR pathway

Hesperetin promotes diabetic wound healing by inhibiting ferroptosis through the activation of SIRT3

Biomimetic Hydrogel Containing Copper Sulfide Nanoparticles and Deferoxamine for Photothermal Therapy of Infected Diabetic Wounds